Ameriprise Financial Inc Dr Reddys Laboratories LTD Transaction History

Ameriprise Financial Inc

  • $415 Billion
  • Q3 2025

A detailed history of Ameriprise Financial Inc transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Ameriprise Financial Inc holds 22,125 shares of RDY stock, worth $308,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,125
Previous 18,300 20.9%
Holding current value
$308,422
Previous $275,000 12.36%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$13.33 - $15.08 $50,987 - $57,681
3,825 Added 20.9%
22,125 $309,000
Q2 2025

Aug 14, 2025
BUY
$12.36 - $16.17 $47,178 - $61,720
3,817 Added 26.36%
18,300 $275,000
Q1 2025

May 14, 2025
SELL
$12.53 - $15.81 $733,280 - $925,232
-58,522 Reduced 80.16%
14,483 $191,000
Q4 2024

Feb 14, 2025
SELL
$13.99 - $79.75 $764,791 - $4.36 Million
-54,667 Reduced 42.82%
73,005 $1.15 Million
Q3 2024

Nov 14, 2024
BUY
$75.41 - $84.21 $903,487 - $1.01 Million
11,981 Added 10.36%
127,672 $10.1 Million
Q2 2024

Aug 14, 2024
SELL
$68.26 - $76.19 $4.77 Million - $5.32 Million
-69,885 Reduced 37.66%
115,691 $8.81 Million
Q1 2024

May 15, 2024
SELL
$67.36 - $77.59 $846,984 - $975,616
-12,574 Reduced 6.35%
185,576 $13.6 Million
Q4 2023

Feb 14, 2024
SELL
$64.27 - $69.9 $15.2 Million - $16.5 Million
-236,304 Reduced 54.39%
198,150 $13.8 Million
Q3 2023

Nov 14, 2023
SELL
$61.9 - $72.77 $590,154 - $693,789
-9,534 Reduced 2.15%
434,454 $29.1 Million
Q2 2023

Aug 14, 2023
BUY
$53.34 - $63.11 $2.56 Million - $3.03 Million
48,032 Added 12.13%
443,988 $28 Million
Q1 2023

May 15, 2023
BUY
$51.63 - $56.93 $18,380 - $20,267
356 Added 0.09%
395,956 $22.5 Million
Q4 2022

Feb 14, 2023
BUY
$51.15 - $57.45 $653,441 - $733,923
12,775 Added 3.34%
395,600 $20.5 Million
Q3 2022

Nov 14, 2022
BUY
$49.9 - $57.32 $41,516 - $47,690
832 Added 0.22%
382,825 $20.9 Million
Q2 2022

Aug 15, 2022
BUY
$49.62 - $58.13 $402,467 - $471,492
8,111 Added 2.17%
381,993 $20.3 Million
Q1 2022

May 16, 2022
SELL
$48.27 - $65.25 $12.5 Million - $16.9 Million
-258,767 Reduced 40.9%
373,882 $18.4 Million
Q4 2021

Feb 14, 2022
BUY
$59.5 - $67.25 $37.6 Million - $42.5 Million
632,649 New
632,649 $35.6 Million
Q3 2021

Nov 15, 2021
SELL
$60.19 - $75.29 $375,043 - $469,131
-6,231 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$62.12 - $74.2 $107,405 - $128,291
-1,729 Reduced 21.72%
6,231 $458,000
Q1 2021

May 17, 2021
BUY
$57.98 - $73.08 $19,191 - $24,189
331 Added 4.34%
7,960 $488,000
Q4 2020

Feb 12, 2021
SELL
$62.61 - $71.29 $22,163 - $25,236
-354 Reduced 4.43%
7,629 $543,000
Q3 2020

Nov 16, 2020
SELL
$51.39 - $72.41 $462 - $651
-9 Reduced 0.11%
7,983 $556,000
Q2 2020

Aug 14, 2020
SELL
$39.55 - $54.65 $304,139 - $420,258
-7,690 Reduced 49.04%
7,992 $424,000
Q1 2020

May 15, 2020
BUY
$34.75 - $45.85 $145,880 - $192,478
4,198 Added 36.56%
15,682 $632,000
Q4 2019

Feb 14, 2020
BUY
$36.66 - $41.78 $73,576 - $83,852
2,007 Added 21.18%
11,484 $467,000
Q3 2019

Nov 14, 2019
SELL
$34.82 - $39.26 $158,013 - $178,161
-4,538 Reduced 32.38%
9,477 $359,000
Q2 2019

Aug 14, 2019
BUY
$36.05 - $42.76 $24,405 - $28,948
677 Added 5.08%
14,015 $525,000
Q1 2019

May 15, 2019
BUY
$35.77 - $40.57 $80,947 - $91,809
2,263 Added 20.43%
13,338 $541,000
Q4 2018

Feb 14, 2019
BUY
$31.89 - $38.44 $162,957 - $196,428
5,110 Added 85.67%
11,075 $418,000
Q3 2018

Nov 14, 2018
BUY
$29.25 - $36.73 $174,476 - $219,094
5,965 New
5,965 $207,000
Q4 2017

Feb 12, 2018
SELL
$34.15 - $37.62 $358,062 - $394,445
-10,485 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$30.11 - $37.72 $315,703 - $395,494
10,485
10,485 $374,000

Others Institutions Holding RDY

# of Institutions
250
Shares Held
94.4M
Call Options Held
0
Put Options Held
0
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.31B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email